HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg

Chronic Hepatitis B, HBsAg, Hepatitis B Vaccine Clinical Trial

Official title: HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg

Status Recruiting

Clinical Trial Summary

Chronic HBV infection is major problem in Asian countries. Years after chronic infection, in some cases serum HBsAg level declines to unmeasurable level. Some of patients develop anti-HBsAb but there is no standard treatment to accelerate HBsAg seroconversion.

There is a study to determine efficacy and safety of HBV vaccine in who is Chronic HBV infection and lost their HBsAg without seroconversion to anti-HBsAb.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Chronic Hepatitis B, HBsAg, Hepatitis B Vaccine
• Hepatitis
• Hepatitis A
• Hepatitis B
• Hepatitis B, Chronic
• Hepatitis, Chronic

• NCT number: NCT03405597
• Study type: Interventional
• Source: Mahidol University
• Contact: Suppawat Jiraphairot
• Phone: +66 877116517
• Email: suppawat_tu@hotmail.com
• Status: Recruiting
• Phase: Phase 3
• Start date: March 30, 2017
• Completion date: June 30, 2018